BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6399840)

  • 1. Antibody-toxin conjugates: a new approach to cancer therapy.
    McIntosh DP
    Adv Biotechnol Processes; 1984; 3():111-39. PubMed ID: 6399840
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of antibody-toxin conjugates.
    Cumber AJ; Forrester JA; Foxwell BM; Ross WC; Thorpe PE
    Methods Enzymol; 1985; 112():207-25. PubMed ID: 3900635
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of cytotoxic antibody-toxin conjugates.
    Cumber AJ; Wawrzynczak EJ
    Methods Mol Biol; 1998; 80():135-44. PubMed ID: 9664370
    [No Abstract]   [Full Text] [Related]  

  • 4. Further report on therapeutic effect of abrin and ricin on human cancers.
    Hsu CT; Lin JY; Tung TC
    Taiwan Yi Xue Hui Za Zhi; 1974 Sep; 73(9):526-42. PubMed ID: 4530824
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoaffinity purification and quantification of antibody-toxin conjugates.
    Wawrzynczak EJ; Cumber AJ
    Methods Mol Biol; 1998; 80():145-53. PubMed ID: 9664371
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mechanism of toxin resistance in cell variants resistant to abrin and ricin.
    Olsnes S; Refsnes K
    Eur J Biochem; 1978 Jul; 88(1):7-15. PubMed ID: 566668
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B.
    Knowles PP; Thorpe PE
    Anal Biochem; 1987 Feb; 160(2):440-3. PubMed ID: 3495199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by tumor cell-targeted toxins.
    Thorburn A; Thorburn J; Frankel AE
    Apoptosis; 2004 Jan; 9(1):19-25. PubMed ID: 14739595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotoxins (author's transl)].
    Richer G; Jansen FK; Gros P
    Nouv Presse Med; 1982 Apr; 11(17):1321-4. PubMed ID: 7079145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of toxic plant lectins in preparing immunotoxins (affinotoxins)].
    Franz H; Pfüller K
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):18-25. PubMed ID: 6349185
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice.
    Godal A; Fodstad O; Pihl A
    Int J Cancer; 1983 Oct; 32(4):515-21. PubMed ID: 6618711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody treatment against pulmonary exposure to abrin confers significantly higher levels of protection than treatment against ricin intoxication.
    Sabo T; Gal Y; Elhanany E; Sapoznikov A; Falach R; Mazor O; Kronman C
    Toxicol Lett; 2015 Sep; 237(2):72-8. PubMed ID: 26051443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric fusion proteins--diphtheria toxin-based.
    Frankel AE; Powell BL; Vallera DA; Neville DM
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1294-301. PubMed ID: 11717818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation and cytotoxic properties of antibody-toxin conjugates.
    Thorpe PE; Ross WC
    Immunol Rev; 1982; 62():119-58. PubMed ID: 7042536
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant toxins as novel therapeutic agents.
    Pastan I; Chaudhary V; FitzGerald DJ
    Annu Rev Biochem; 1992; 61():331-54. PubMed ID: 1497314
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibody targeting of anti-cancer agents.
    Baldwin RW; Byers VS
    Springer Semin Immunopathol; 1986; 9(1):39-50. PubMed ID: 2425442
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor effects of abrin and ricin used singly and in combination with cisplatin.
    Walker EM; Gale GR; Glassman AB; Atkins LM; Bennett CE; Burgis JT
    Ann Clin Lab Sci; 1984; 14(1):10-20. PubMed ID: 6538076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotoxin therapy of neoplasms].
    Hashimoto N; Takatsu K
    Nihon Rinsho; 1983; 41(4):825-9. PubMed ID: 6350651
    [No Abstract]   [Full Text] [Related]  

  • 19. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA; Bizuneh A; Frackelton AR
    Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative immunoassay of biotoxins on hydrogel-based protein microchips.
    Rubina AY; Dyukova VI; Dementieva EI; Stomakhin AA; Nesmeyanov VA; Grishin EV; Zasedatelev AS
    Anal Biochem; 2005 May; 340(2):317-29. PubMed ID: 15840505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.